{"prompt": "['Amended Clinical Trial Protocol NO 03', '18-Apr-2018', 'ACT14656', 'Version number: 1', '13. Chauhan A, Mullins PA, Taylor G, Petch MC, Schofield PM. Both endothelium-dependent', 'and endothelium-independent function is impaired in patients with angina pectoris and normal', 'coronary angiograms. Eur Heart J. 1997;18:60-8.', '14. Sestito A, Lanza GA, Di Monaco A, Lamendola P, Carreri G, Tarzia P et al. Relation between', 'cardiovascular risk factors and coronary microvascular dysfunction in cardiac syndrome X. J', 'Cardiovasc Med (Hagerstown). 2011;12:322-7.', '15. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired', 'endothelium-dependent coronary vasodilation in patients with angina pectoris and normal', 'coronary angiograms. N Engl J Med. 1993;328:1659-64', '16. Shimokawa H, Satoh K. 2015 ATVB Plenary Lecture: translational research on rho-kinase in', 'cardiovascular medicine Arterioscler Thromb Vasc Biol. 2015;35(8):1756-69.', '17. Kanda T, Wakino S, Hayashi K, Homma K, Ozawa Y, Saruta T. Effect of fasudil on Rho-', 'kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats. Kidney', 'Int. 2003;64:2009-19.', '18. Sawada N, Itoh H, Ueyama K, Yamashita J, DoiK, Chun TH, et al. Inhibition of rho-', 'associated kinase results in suppression of neointimal formation of balloon-injured arteries.', 'Circulation. 2000;101(17):2030-3.', '19. Kataoka C, Egashira K, Inoue S, Takemoto M, Ni W, Koyanagi M, et al. Important role of', 'Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by', 'long-term blockade of nitric oxide synthesis in rats. Hypertension. 2002;39:245-50.', '20. DoeZ, Fukumoto Y, Takaki A, Tawara S, Ohashi J, Nakano M, et al. Evidence for Rho-', 'Kinase activation in patients with pulmonary arterial hypertension. Circ J. 2009;73:1731-9.', '21. Hata T, Goto C, Soga J, Hidaka T, Fujii Y, Idei N, et al. Measurement of Rho-associated', 'kinase (ROCK) activity in humans: Validity of leukocyte p-MBS/t-MBS in comparison with', 'vascular response to fasudil. Atherosclerosis. 2011;214:117-21.', '22. Kikuchi Y, Yasuda S, Aizawa K, Tsuburaya R, Ito Y, Takeda M, et al. Enhanced Rho-Kinase', 'activity in circulating neutrophils of patients with vasospastic angina. A Possible Biomarker', 'for Diagnosis and Disease Activity Assessment. J Am Coll Cardiol. 2011;58:1231-7.', '23. L\u00f6hn M, Plettenburg O, Ivashchenko Y, Kannt A, Hofmeister A, Kadereit D, Schaefer M,', \"Linz W, Kohlmann M, Herbert JM, Janiak P, O'Connor SE, Ruetten H. Pharmacological\", 'characterization of SAR407899, a novel rho-kinase inhibitor. Hypertension. 2009;54(3):676-', '83.', '24. Shimokawa H, Sunamura S, Satoh K. RhoA/Rho-Kinase in the Cardiovascular System. Circ', 'Res. 2016;118(2):352-66.', 'Property of the Sanofi Group - strictly confidential', 'Page 94', '(electronic 4.0)']['Amended Clinical Trial Protocol NO 03', '18-Apr-2018', 'ACT14656', 'Version number: 1', '25. Ming-Jui Hung, Wen-Jin Cherng. Clinical Applications of Transthoracic Doppler', 'Echocardiographic Coronary Flow Reserve. Measurements in the Left Anterior Descending', 'Coronary Artery. Journal of Medical Ultrasound. 2011;19:115-21.', '26. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A et al. 2013 ESC', 'guidelines on the management of stable coronary artery disease: The Task Force on the', 'management of stable coronary artery disease of the European Society of Cardiology. Eur', 'Heart J.2013;34(38):2949-3003.', '27. Berry C. Fractional flow reserve, coronary flow reserve and the index of microvascular', 'resistance in clinical practice. Radcliffe Cardiology. 2014;1-6.', '28. Spertus JA, Winder JA, Dewhurst T, Deyo R, Prodzinski J, McDonell M, et al. Development', 'and evaluation of the Seattle Angina Questionnaire: a new functional status measure for', 'coronary artery disease. J Am Coll Cardiol. 1995;25:333-41.', '29. Chan PS, Jones PG, Arnold SA, Spertus JA. Development and validation of a short version of', 'the Seattle angina questionnaire. Circ Cardiovasc Qual Outcomes. 2014;7:640-7.', '30. El Fakhri G, Kardan A, Sitek A, Dorbala S, Abi-Hatem N, Lahoud Y et al. Reproducibility', 'and accuracy of quantitative myocardial blood flow assessment with (82)Rl PET: comparison', 'with (13)N-ammonia PET. J Nucl Med. 2009;50:1062-71.', '31. El Fakhri G, Guerin G, Sitek A, Curillova Z, Agnostopoulos C, Dorbala S et al. Absolute', 'myocardial blood flow quantification in Rb-82 cardiac PET using generalized factor and', 'compartment analysis: a reproducibility study. Eur J Nuel Med Molec Imaging. 2006;33:S217.', '32. Murthy VL, Lee BC, Sitek A, Naya M, Moody J, Polavarapu V, Ficaro EP and Di Carli MF.', 'Comparison and prognostic validation of multiple methods of quantification of myocardial', 'blood flow with 82Rb PET. J Nuel Med. 2014;55:1952-8.', 'Property of the Sanofi Group - strictly confidential', 'Page 95', '(electronic 4.0)']\n\n###\n\n", "completion": "END"}